Zydus’ ZYCUBO May Be the Proof Point the Industry Needed
For decades, Indian pharma has won by playing the volume game—generics, cost arbitrage, regulatory stamina, scale. That model built giants. It also hit a ceiling.
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
